iBio IBIO
NASDAQ IBIO
$1.17 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

iBio (IBIO) Raw Materials (2021 - 2022)

Updated

iBio (IBIO) posted Raw Materials of $3.9 million for fiscal Q4 2022 (quarter ended Jun 30, 2022), up 18.7% from the prior quarter.

Analysis

iBio (IBIO) Raw Materials (2021 - 2022) Analysis & Trends

Since fiscal Q1 2022, iBio has reported Raw Materials for 4 quarters.

  • According to Business Quant data, Raw Materials for the three prior fiscal quarters was $3.28 million (Q3 2022), $1.96 million (Q2 2022) and $487,000 (Q1 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 iBio 121.75 Mn 121.75 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 3.90 Mn
Mar 31, 2022 3.28 Mn
Dec 31, 2021 1.96 Mn
Sep 30, 2021 487,000.00
API Access

iBio Raw Materials API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=raw-materials&ticker=IBIO&period=max&api_key=YOUR_API_KEY